CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy (vol 139, pg 95, 2013)

被引：0
|
作者：
Teft, Wendy A. [1 ]
Gong, Inna Y. [1 ,2 ]
Dingle, Brian [3 ]
Potvin, Kylea [3 ]
Younus, Jawaid [3 ]
Vandenberg, Theodore A. [3 ]
Brackstone, Muriel [3 ,4 ]
Perera, Francisco E. [3 ]
Choi, Yun-Hee [5 ]
Zou, Guangyong [5 ]
Legan, Robin M. [1 ]
Tirona, Rommel G. [1 ,2 ]
Kim, Richard B. [1 ,2 ,3 ,6 ]
机构：
[1] Univ Western Ontario, Dept Med, Div Clin Pharmacol, London, ON, Canada
[2] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada
[3] Univ Western Ontario, Dept Oncol, London, ON, Canada
[4] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada
[5] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada
[6] LHSC Univ Hosp, Dept Med, London, ON N6A 5A5, Canada
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2013年 / 142卷 / 01期
关键词：
D O I：
10.1007/s10549-013-2706-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [41] In vitro and in silico inhibition performance of choline against CYP1A2, CYP2D6 and CYP3A4
    Mateev, Emilio
    Balkanska-Mitkova, Tony
    Peikova, Lily
    Dimitrova, Maria
    Kondeva-Burdina, Magdalena
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2022, 36 (01) : 925 - 932
  • [42] Mechanism-based inhibition of CYP3A4 and CYP2D6 by Indonesian medicinal plants
    Subehan
    Usia, Tepy
    Iwata, Hiroshi
    Kadota, Shigetoshi
    Tezuka, Yasuhiro
    JOURNAL OF ETHNOPHARMACOLOGY, 2006, 105 (03) : 449 - 455
  • [43] The In Vitro Inhibition of Human CYP1A2, CYP2D6 and CYP3A4 by Tetrahydropalmatine, Neferine and Berberine
    Zhao, Yong
    Hellum, Bent Havard
    Liang, Aihua
    Nilsen, Odd Georg
    PHYTOTHERAPY RESEARCH, 2012, 26 (02) : 277 - 283
  • [44] Drug metabolism of CYP3A4, CYP2C9 and CYP2D6 substrates in pigs and humans
    Thorn, Helena Anna
    Lundahl, Anna
    Schrickx, Johannes Antonius
    Dickinson, Paul Alfred
    Lennernas, Hans
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 43 (03) : 89 - 98
  • [45] Determinant role of CYP2D6 and CYP3A4 pathways on the antinociceptive effects of oxycodone.
    Samer, C
    Daali, Y
    Rebsamen, M
    Chiappe, A
    Desmeules, J
    Dayer, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P57 - P57
  • [46] The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites
    Chapron, Brian D.
    Dinh, Jean C.
    Toren, Paul C.
    Gaedigk, Andrea
    Leeder, J. Steven
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (11) : 1113 - 1120
  • [47] Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicities
    Kwok, Wang Chun
    Lam, David Chi Leung
    Ip, Mary Sau Man
    Tam, Terence Chi Chun
    Ho, James Chung Man
    ANTI-CANCER DRUGS, 2022, 33 (10) : 1139 - 1144
  • [48] CYP3A4*22 is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen
    Antunes, Marina Venzon
    de Oliveira, Vanessa
    Raymundo, Suziane
    Staudt, Dilana Elisabeth
    Goessling, Gustavo
    Biazus, Jorge Villanova
    Cavalheiro, Jose Antonio
    Rosa, Daniela Dornelles
    Mathy, Genevieve
    Wallemacq, Pierre
    Linden, Rafael
    Schwartsmann, Gilberto
    Haufroid, Vincent
    PHARMACOGENOMICS, 2015, 16 (06) : 601 - 617
  • [49] Modeling and simulation of CYP2D6 PM and CYP3A4/5 PM and their effects on population pharmacokinetics of tamoxifen and its main metabolites
    Ximenez, J. P.
    D'Agate, S.
    Locci de Oliveira, M.
    Marques Pereira, M. P.
    Moreira Andrade, J.
    Suarez-Kurtz, G.
    Della Pasqua, O.
    Lanchote, V. L.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S73 - S73
  • [50] The Effect of CYP2B6, CYP2D6, and CYP3A4 Alleles on Methadone Binding: A Molecular Docking Study
    Kamal, Nik Nur Syazana Bt Nik Mohamed
    Lim, Theam Soon
    Tye, Gee Jun
    Ismail, Rusli
    Choong, Yee Siew
    JOURNAL OF CHEMISTRY, 2013, 2013
12345